A

Abingworth Portfolio holdings

AUM $307M
This Quarter Return
+20.28%
1 Year Return
+93.6%
3 Year Return
+207.29%
5 Year Return
+452.78%
10 Year Return
AUM
$134M
AUM Growth
+$134M
Cap. Flow
+$3.65M
Cap. Flow %
2.72%
Top 10 Hldgs %
93.35%
Holding
19
New
2
Increased
1
Reduced
1
Closed
2
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
CRSP icon
1
CRISPR Therapeutics
CRSP
$4.71B
$56.6M 42.2% 2,601,814
PRTK
2
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$25.1M 18.67% 1,301,413
SIEN
3
DELISTED
Sientra, Inc.
SIEN
$18.5M 13.75% 2,199,012
CBAY
4
DELISTED
Cymabay Therapeutics
CBAY
$6.86M 5.11% 1,600,000
CASC
5
DELISTED
Cascadian Therapeutics, Inc.
CASC
$3.83M 2.85% +925,000 New +$3.83M
CHMA
6
DELISTED
Chiasma, Inc. Common Stock
CHMA
$3.54M 2.64% 2,080,595
TARA icon
7
Protara Therapeutics
TARA
$120M
$3.43M 2.56% 2,017,872
EVAR
8
DELISTED
Lombard Medical, Inc.
EVAR
$2.71M 2.02% 3,473,452
CLLS
9
Cellectis
CLLS
$258M
$2.4M 1.79% 100,000
DERM
10
DELISTED
Dermira, Inc.
DERM
$2.39M 1.78% 70,000
IMDZ
11
DELISTED
Immune Design Corp.
IMDZ
$2.38M 1.77% 352,300 +155,000 +79% +$1.05M
AUPH icon
12
Aurinia Pharmaceuticals
AUPH
$1.58B
$1.85M 1.38% +252,129 New +$1.85M
OCGN icon
13
Ocugen
OCGN
$319M
$1.48M 1.1% 888,889
ADAP
14
Adaptimmune Therapeutics
ADAP
$15.6M
$1.38M 1.02% 250,000
SENS icon
15
Senseonics Holdings
SENS
$374M
$920K 0.69% 516,882
INNL
16
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
$586K 0.44% 537,235
NOVN
17
DELISTED
Novan, Inc. Common Stock
NOVN
$337K 0.25% 53,367 -146,633 -73% -$926K
DRNA
18
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
-337,825 Closed -$973K
ANTH
19
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
-861,723 Closed -$1.17M